We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.  Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go: Extended investment: £87,500
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go: Extended investment: £150,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Liquid supplements are a faster acting and a more efficient way for the body to absorb key active ingredients than taking pills. Our scientists have developed formulations involving leading active ingredients such as collagen in order to create the perfect wellness solution in every bottle. Each LQ bottle is packed full of 9 or more active ingredients all in one easy to drink, daily 50 m bottle.
days to go: Expired investment: £355,000
Simply get results limited are a universal data analytics solution, improving financial performance through people. They have established a client portfolio of household names and are profitable with over £400k of revenue. They save organisations tens of millions of pounds using their proprietary software and unique algorithms to find patterns and trends to present unseen opportunities.
days to go: Expired investment: £205,000
Studio Pictures Limited is a UK based production company that specialises in the development of high-quality British film and TV projects. The company's interest predominantly lies within the British film and television industry that can be created within budget ranging from £1 million - £15 million. The company has established relationships with studio houses such as Warner Bros., Sony Pictures and Lionsgate and aims to build upon projects that can be made into a franchise. Their production, A Steet Cat Named Bob, went on to be distributed by Sony Pictures in the UK and had a Royal Premiere in London. Studio Pictures Limited will consider putting up to a maximum of 20% of the budget for each project as equity, on a case by case basis, subject to company reserves. With the proceeds, the company will grow and scale the business. It will become a tenant at Twickenham Studios in West London and look to profitable emerging markets, i.e. streaming, animation and interactive movies to become one of the leading UK production companies.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
HeadBox are trying to make the process of booking the perfect space for your client or work based event simpler. HeadBox are looking to do this by using their efficient platform to connect guests and hosts directly. Hosts are able to list their space on the platform and guests are able to browse the site to find their ideal space.
days to go: Expired investment: £762,000
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go: Expired investment: Withheld
Beacon is a company that offers software and supporting services to help a client optimise their digital marketing efforts and improve their marketing Return-on-Investment (ROI). The company offers clients services like campaign management, PPC (Pay Per Click) campaign analytics, social media analytics, and anti-fraudulent click system etc. Using the company's portal, marketers can compare costs and revenue across all digital channels, channel by channel, and with their off-line marketing efforts. Beacon aims at removing ‘non-human clicks’ and giving direct independent attribution of emails, posts, ad’s, etc. to specific website actions and business goals thereby improving engagement and reducing costs. According to Stratistics Market Research Consulting, the web analytics tools market is expected to reach $4.9 billion by 2022, growing at a Compound Annual Growth Rate (CAGR) of 20.8%, in which, Beacon aims to be a leading contender. The company will use the investment to grow its business across different verticals.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £240,000
Antikor is developing a new cancer treatment using antibody fragment drug conjugate which penetrates solid tumours to destroy cancer cells. Their new treatment only targets pre-determined cancer cells, so healthy cells are not affected.  Biopharma is predicted to become the core of the pharmaceutical industry after undergoing transformation in the laboratory, technology and operations  
days to go: Expired investment: £125,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph